BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38267302)

  • 1. Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic.
    McFadden J; Hardesty J; Schroeder C; Vance GH; Boris RS
    Urol Oncol; 2024 Mar; 42(3):72.e19-72.e25. PubMed ID: 38267302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
    Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
    Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
    Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience.
    Rabban JT; Chan E; Mak J; Zaloudek C; Garg K
    Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Piedimonte S; Power J; Foulkes WD; Weber E; Palma L; Schiavi A; Ambrosio E; Konci R; Gilbert L; Jardon K; Baret L; Zeng X
    Int J Gynecol Cancer; 2020 Nov; 30(11):1757-1761. PubMed ID: 32759180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
    Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
    Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of hereditary renal cell carcinoma syndromes.
    Wu CL
    Semin Diagn Pathol; 2024 May; 41(3):118. PubMed ID: 38195331
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
    Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
    Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
    Boitano TKL; Barrington DA; Batra S; McGwin G; Turner TB; Farmer MB; Brown AM; Straughn MJ; Leath CA
    Gynecol Oncol; 2019 Aug; 154(2):379-382. PubMed ID: 31196574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the hereditary background of renal cancer in Denmark.
    Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
    PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry.
    Sturgeon D; McCutcheon T; Geiger TM; Muldoon RL; Herline AJ; Wise PE
    Dis Colon Rectum; 2013 Mar; 56(3):308-14. PubMed ID: 23392144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.
    Muller M; Guillaud-Bataille M; Salleron J; Genestie C; Deveaux S; Slama A; de Paillerets BB; Richard S; Benusiglio PR; Ferlicot S
    Mod Pathol; 2018 Jun; 31(6):974-983. PubMed ID: 29410489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.
    Shuch B; Ricketts CJ; Vocke CD; Komiya T; Middelton LA; Kauffman EC; Merino MJ; Metwalli AR; Dennis P; Linehan WM
    J Urol; 2013 Dec; 190(6):1990-8. PubMed ID: 23764071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic evaluation of patients and families with concern for hereditary endocrine tumor syndromes.
    Anderson JL; Pilarski R; Kirschner L; Brock P
    Fam Cancer; 2022 Jan; 21(1):93-100. PubMed ID: 33409929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
    Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
    Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.